Genworth Finl Inc Stock Price, News & Analysis

Genworth Financial (NYSE: GNW) will release its Q3 2025 earnings after market close on November 5, 2025 and host an earnings conference call on November 6, 2025 at 10:00 a.m. ET. The company's earnings release, summary presentation, and financial supplement will be posted at investor.genworth.com when released.

The conference call is accessible by telephone (800-330-6710 U.S.; 213-279-1505 outside U.S.; conference ID 2260685) and via webcast with registration at investor.genworth.com. Participants are recommended to join 15 minutes early. A webcast replay will be available on the company website for one year.

Genworth's publicly traded subsidiary Enact Holdings (Nasdaq: ACT) will hold its Q3 2025 call on November 6, 2025 at 8:00 a.m. ET; webcast registration is at ir.enactmi.com and pre-registration is required for live Q&A participation.

CareScout (NYSE:GNW) has launched CareScout Care Assurance, its first long-term care (LTC) insurance product. The new solution combines financial protection for long-term care expenses with access to the CareScout Quality Network, a nationwide network of vetted aging care providers offering preferred pricing.

The product offers benefit options between $50,000 and $250,000, with daily benefit maximums from $50 to $200. Available to individuals aged 40-65, it features compound inflation protection options of 1%, 3%, and 5%, along with couples' rates and preferential pricing for healthier applicants. The fully digital platform streamlines the application-to-delivery process and provides access to caregiver support resources, customer service, and planning tools.

Genworth Financial (NYSE: GNW) has announced a new $350 million share repurchase program, supplementing its existing $700 million program which has $16 million remaining as of September 17, 2025. The program, funded by holding company cash and supported by strong cash flows from subsidiary Enact Holdings, demonstrates the company's commitment to shareholder returns.

The company sized the program based on Enact Holdings' projected cash flows, excluding potential proceeds from ongoing litigation with AXA S.A. and Santander Cards UK Limited. Genworth may consider expanding the program further pending Santander's appeal outcome. The repurchases will be executed through various means, including open market transactions and Rule 10b5-1 trading plans, with no expiration date.

Genworth Financial (NYSE: GNW) has received a credit rating upgrade from Moody's, with its backed senior unsecured debt rating improving to Baa3 from Ba1, representing a one-notch upgrade with a stable outlook.

The upgrade reflects Genworth's strengthened financial position and strategic execution, particularly highlighting the company's valuable 81% ownership stake in Enact. The Insurer Financial Strength ratings of Genworth's life insurance subsidiaries remain unchanged by this action.

Genworth Financial (NYSE:GNW) reported Q2 2025 results with net income of $51M ($0.12 per diluted share) and adjusted operating income of $68M ($0.16 per diluted share). The company's mortgage insurance subsidiary, Enact, delivered strong performance with $141M in adjusted operating income and distributed $94M in capital returns to Genworth.

Key highlights include $30M in share repurchases during the quarter at an average price of $7.01, bringing total repurchases to $620M since program inception. The Long-Term Care segment achieved $41M in gross incremental premium approvals. The company maintained a strong financial position with holding company cash and liquid assets of $248M and U.S. life insurance companies' RBC ratio of 304%.

Genworth Financial (NYSE: GNW) announced a favorable UK High Court ruling in a Payment Protection Insurance (PPI) case involving AXA and Santander. The court found Santander liable for PPI mis-selling losses and awarded AXA approximately £680 million ($911 million) in damages, interest, and costs.

Due to prior agreements with AXA, Genworth expects to recover approximately $750 million once the judgment is paid and any appeals are resolved. The company plans to use these funds for three main purposes: investing in CareScout growth, returning cash to shareholders through buybacks, and opportunistically reducing debt.

Genworth Financial (NYSE: GNW) has scheduled its second quarter 2025 earnings conference call for July 31, 2025, at 9:00 a.m. ET. The company will release its earnings report after market close on July 30, 2025.

The conference call will be accessible via telephone (888-208-1820 or 323-794-2110) with conference ID #8808137, and through webcast registration at the investor relations website. Additionally, Genworth's subsidiary Enact Holdings (Nasdaq: ACT) will hold its Q2 earnings call on the same day at 8:00 a.m. ET.

Genworth Financial (NYSE: GNW) held its 2025 annual meeting of stockholders, where all ten director nominees were successfully re-elected to the board. Stockholders approved several key measures including: the advisory vote on named executive officer compensation, the 2025 Omnibus Incentive Plan, and ratified KPMG LLP as the company's independent registered public accounting firm for 2025. Additionally, stockholders approved an amendment to remove the "Pass-Through Voting" provision from the Amended and Restated Certificate of Incorporation of Genworth Holdings, Inc.

Genworth Financial reported Q1 2025 financial results with a net income of $54 million ($0.13 per diluted share) and adjusted operating income of $51 million ($0.12 per diluted share). The company executed $45M in share repurchases at an average price of $6.91 per share.

Key highlights include:

• Enact segment delivered $137M in adjusted operating income and distributed $76M to Genworth
• Long-term care insurance achieved $24M in gross incremental premium approvals
• CareScout Quality Network expanded to cover 90% of the U.S. aged 65-plus population
• U.S. life insurance companies maintained an RBC ratio of 304%
• Holding company ended with $211M in cash and liquid assets

The company continues to focus on delivering value through Enact, ensuring self-sustainability of legacy insurance operations, and scaling CareScout as a growth engine. Notable achievements include $590M in total share repurchases to date at an average price of $5.73 per share.